Literature DB >> 19734167

Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes.

Maria Alícia Carrillo-Sepúlveda1, Graziela S Ceravolo, Zuleica Bruno Fortes, Maria Helena Carvalho, Rita C Tostes, Francisco R Laurindo, R Clinton Webb, Maria Luiza M Barreto-Chaves.   

Abstract

AIMS: Thyroid hormone (TH) rapidly relaxes vascular smooth muscle cells (VSMCs). However, the mechanisms involved in this effect remain unclear. We hypothesize that TH-induced rapid vascular relaxation is mediated by VSMC-derived nitric oxide (NO) production and is associated with the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signalling pathway. METHODS AND
RESULTS: NO levels were determined using a NO-specific fluorescent dye (DAF-2) and nitrite (NO2-) levels. Expression of NO synthase (NOS) isoforms and proteins of the PI3K/Akt pathway was determined by both western blotting and immunocytochemistry. Myosin light chain (MLC) phosphorylation levels were also investigated by western blotting. Exposure of cultured VSMCs from rat thoracic aortas to triiodothyronine (T3) resulted in a significant decrease of MLC phosphorylation levels. T3 also induced a rapid increase in Akt phosphorylation and increased NO production in a dose-dependent manner (0.001-1 microM). VSMCs stimulated with T3 for 30 min showed an increase in the expression of all three NOS isoforms and augmented NO production, effects that were prevented by inhibitors of PI3K. Vascular reactivity studies showed that vessels treated with T3 displayed a decreased response to phenylephrine, which was reversed by NOS inhibition. These data suggest that T3 treatment induces greater generation of NO both in aorta and VSMCs and that this phenomenon is endothelium independent. In addition, these findings show for the first time that the PI3K/Akt signalling pathway is involved in T3-induced NO production by VSMCs, which occurs with expressive participation of inducible and neuronal NOS.
CONCLUSION: Our data strongly indicate that T3 causes NO-dependent rapid relaxation of VSMC and that this effect is mediated by the PI3K/Akt signalling pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734167      PMCID: PMC3031311          DOI: 10.1093/cvr/cvp304

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  46 in total

Review 1.  Thyroid hormone and the cardiovascular system.

Authors:  I Klein; K Ojamaa
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  Physiological and molecular basis of thyroid hormone action.

Authors:  P M Yen
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

3.  Thyroid hormone regulation of phospholamban phosphorylation in the rat heart.

Authors:  K Ojamaa; A Kenessey; I Klein
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

4.  Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins.

Authors:  N F Worth; B E Rolfe; J Song; G R Campbell
Journal:  Cell Motil Cytoskeleton       Date:  2001-07

5.  Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser(1179).

Authors:  M Montagnani; H Chen; V A Barr; M J Quon
Journal:  J Biol Chem       Date:  2001-06-11       Impact factor: 5.157

6.  Impact of hyperthyroidism and its correction on vascular reactivity in humans.

Authors:  R Napoli; B Biondi; V Guardasole; M Matarazzo; F Pardo; V Angelini; S Fazio; L Saccà
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

7.  L-Arginine effects on blood pressure and renal function of intrauterine restricted rats.

Authors:  Gisele Malavazi Alves; Marco Antônio Barão; Letícia Negumi Odo; Guiomar Nascimento Gomes; Maria do Carmo Pinho Franco Md; Dorothy Nigro; Sandra Regina R Lucas; Francisco Rafael Martins Laurindo; Laura Inês Ventura Brandizzi; Frida Zaladek Gil
Journal:  Pediatr Nephrol       Date:  2002-08-09       Impact factor: 3.714

8.  Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase.

Authors:  H Mizuma; M Murakami; M Mori
Journal:  Circ Res       Date:  2001-02-16       Impact factor: 17.367

9.  Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.

Authors:  Gabriela Placoná Diniz; Marcela Sorelli Carneiro-Ramos; Maria Luiza Morais Barreto-Chaves
Journal:  Basic Res Cardiol       Date:  2009-07-09       Impact factor: 17.165

Review 10.  Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator.

Authors:  Chen Yan; Dongsoo Kim; Toru Aizawa; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-01       Impact factor: 8.311

View more
  46 in total

1.  Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal.

Authors:  Benjamin Van Tassell; George F Wohlford; Joyce D Linderman; Sheila Smith; Sahzene Yavuz; Frank Pucino; Francesco S Celi
Journal:  Thyroid       Date:  2019-09-12       Impact factor: 6.568

2.  Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats.

Authors:  Maria Alicia Carrillo-Sepulveda; Kathryn Spitler; Deepesh Pandey; Dan E Berkowitz; Takayuki Matsumoto
Journal:  J Mol Med (Berl)       Date:  2015-07-17       Impact factor: 4.599

3.  In vivo selective expression of thyroid hormone receptor α1 in endothelial cells attenuates myocardial injury in experimental myocardial infarction in mice.

Authors:  Jorge Suarez; Hong Wang; Brian T Scott; Haiyun Ling; Ayako Makino; Eric Swanson; Joan Heller Brown; Jorge A Suarez; Shera Feinstein; Julieta Diaz-Juarez; Wolfgang H Dillmann
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-05-21       Impact factor: 3.619

4.  Esophagus motility in overt hypothyroidism.

Authors:  Muzaffer İlhan; Elif Arabaci; Seda Turgut; Ozcan Karaman; Ahmet Danalioglu; Ertugrul Tasan
Journal:  J Endocrinol Invest       Date:  2014-05-21       Impact factor: 4.256

Review 5.  Is nitric oxide a hormone?

Authors:  Asghar Ghasemi; Saleh Zahediasl
Journal:  Iran Biomed J       Date:  2011

6.  Thyroid hormone deiodinases D1, D2, and D3 are expressed in human endothelial dermal microvascular line: effects of thyroid hormones.

Authors:  Laura Sabatino; Valter Lubrano; Silvana Balzan; Claudia Kusmic; Serena Del Turco; Giorgio Iervasi
Journal:  Mol Cell Biochem       Date:  2014-10-11       Impact factor: 3.396

7.  Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice.

Authors:  Ivson Bezerra da Silva; Dayane Aparecida Gomes; Natalia Alenina; Michael Bader; Robson Augusto Dos Santos; Maria Luiza M Barreto-Chaves
Journal:  Heart Vessels       Date:  2017-12-07       Impact factor: 2.037

8.  Inappropriate heat dissipation ignites brown fat thermogenesis in mice with a mutant thyroid hormone receptor α1.

Authors:  Amy Warner; Awahan Rahman; Peter Solsjö; Kristina Gottschling; Benjamin Davis; Björn Vennström; Anders Arner; Jens Mittag
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-17       Impact factor: 11.205

9.  Type 2 Iodothyronine Deiodinase Activity Is Required for Rapid Stimulation of PI3K by Thyroxine in Human Umbilical Vein Endothelial Cells.

Authors:  Tomoyuki Aoki; Katsuhiko Tsunekawa; Osamu Araki; Takayuki Ogiwara; Makoto Nara; Hiroyuki Sumino; Takao Kimura; Masami Murakami
Journal:  Endocrinology       Date:  2015-08-18       Impact factor: 4.736

10.  Effect of thyroid hormone-nitric oxide interaction on tumor growth, angiogenesis, and aminopeptidase activity in mice.

Authors:  Javier Carmona-Cortés; Isabel Rodríguez-Gómez; Rosemary Wangensteen; Inmaculada Banegas; Ángel M García-Lora; Andrés Quesada; Antonio Osuna; Félix Vargas
Journal:  Tumour Biol       Date:  2014-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.